Member Info for jmfw

AS has told us that it will take 10mins for an indication, but 20mins for confirmation. So does it take 5mins to register etc, then take the test & wait 20mins for the result. Hope it is ours, but still happy to wait for official announcement(s).

What takes 5 minutes?

my 6 pennyworth:
the contract is between The Authority & GAD
3.1.10 Test Developer to grant a licence to Mologic......
3.3 Supplier not the 'manufacturer of record'

If neither Mologic nor GAD, whose IPR is being licensed for manufacture?

choo...the presentation slide quite clearly states
verification of manufactured batches against prod spec (end april)
CE marking early May
commercial rollout May
So I'll ask again, what timeline will be missed?

choo...what timeline?

ndn.....thanks

ndn....didn't ask about your concerns. My curiosity is about why you are holding while you have so many doubts. As intimated in my original post I would be 'waiting in the wings' for a suitable entry point.

ndn.......you really are doubtful about the lfd. If you are holding, why?

ndn, I'm confident. For me it's 'when' not 'if'. If I was in the latter camp, I would no longer be holding & would be waiting for a re-entry point, as I am very hopeful for the therapeutics business.

If 43 & 45 are avacta, it would suggest bams has been validated.
https://www.gov.uk/government/publications/assessment-and-procurement-of-coronavirus-covid-19-tests/products-in-the-pipeline-tvg-validation-concluded-or-paused

I notice that 43 ....mass spectrometry via a different validation route....has been validated. Could this be BAMS?

MMs happy to take in excess of 20k last 2 mins. quoted 232.25 & then 234.65

Tender dated 5 March states 'Preview Notice'. Also changes under headings 'CPV codes', 'Reference' & 'Indicators'.
Probably just refinements.

NDN, be surprised if shareholders (of any company) were to be advised every time an evaluation had been completed, & not even sure it's obligatory to rns. However, following the evaluation I'm sure we'll soon be advised the status of BAMS....by rns & not vox.

NDN, if that as a reply to me, please be more specific. I can be specific about what was advised & when, so wonder if it's your interpretation of what was stated rather than what was actually stated, which was:
"This evaluation is expected to continue for another two or three weeks and the Group is establishing outsourced manufacturing capacity for the BAMS tests in collaboration with Adeptrix so that it is in a position to formally validate the diagnostic product as soon as possible. Avacta is also in discussions with a large commercial partner to provide a route to market for the BAMS assay."
No promise there.

NDN, what exactly was the promise for BAMs that has been missed & where was it advised?

RAC is a SPAC with $137.5m cash
https://www.researchalliancecorp.com/

Avacta's potential worth so much more..... 10s of billions. Why settle for less?

Just noticed that my platform charges 1% stamp duty for buying eqt. Didn't think it was applicable to AIM listed stocks . Grateful for comments/advice. Thanks

So you did roundhowe. Apologies.